Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Clinical trial NCT02638805 · COMPLETED
Trial details
- NCT number
- NCT02638805
- Sponsor
- Intarcia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-10-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.